No Detail Found!

Comparative Analysis of Gene Expression Pro les in Ovarian Clear Cell Carcinoma and High-Grade Serous Ovarian Cancer

Author(s)
Chen Ye Clinical Laboratory, The Second People's Hospital of Jingdezhen, Key Laboratory of Cell and Molecular Medicine,Jingdezhen,China
Gang Hu National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Jiangxi Medical College, Nanchang University,Nanchang,China
Xiaoni Zhou Department of Obstetrics and Gynaecology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University,Nanchang,China
Wen Deng Clinical Laboratory, The Second People's Hospital of Jingdezhen, Key Laboratory of Cell and Molecular Medicine,Jingdezhen,China
Kai Hu Clinical Laboratory, The Second People's Hospital of Jingdezhen, Key Laboratory of Cell and Molecular Medicine,Jingdezhen,China
Minglei Fu Clinical Laboratory, The Second People's Hospital of Jingdezhen, Key Laboratory of Cell and Molecular Medicine,Jingdezhen,China
Abstract
Objective: To evaluate disparities in gene expression pro les between Ovarian Clear Cell Carcinoma (OCCC) and High-Grade Serous Ovarian Carcinoma (HGSOC). Study Design: A descriptive study. Place and Duration of the Study: The Second People's Hospital of Jingdezhen, Jiangxi, China, between 3 1st December 2017 and December 2023. Methodology: Basic and clinical diagnostic information, along with genetic test reports, were compiled from all patients within the included groups. Di erential gene expression between the two cohorts was scrutinised to elucidate its clinical signi cance. Results: Comparative analysis revealed nine di erentially expressed genes in OCCC relative to HGSOC, with six exhibiting signi cant disparities (p <0.05). These genes are implicated in pivotal cellular processes including the cell cycle, apoptosis, DNA damage repair, and the PI3K pathway. Notably, aberrant expression patterns, such as overexpression of MET and downregulation of PTEN and SMARCA4, correlated with adverse prognosis and survival outcomes in selected patients. Conclusion: Distinctive gene expression pro les between OCCC and HGSOC underscore disparate tumorigenic mechanisms, thereby laying a foundation for the tailored therapeutic interventions. Further elucidation of the identi ed di erentially expressed genes is warranted to delineate their role in OCCC pathogenesis and prognostic signi cance.
Publication Details
Page(s) 1066-1072
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 34, Issue: 9, Year: 2024

Request the full text from PASTIC

Keywords
High-grade serous ovarian cancer, Homologous recombination repair, Ovarian clear cell carcinoma, Gene expression pro les
0

Citations

0

Downloads

64

Views